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Abstract The Ure2p yeast prion-like protein was translated in 
vitro in the presence of labeled [35S]methionine in either rabbit 
reticulocyte lysate (RRL) or wheat germ extract (WGE) cell-free 
systems. When subjected to proteinase K digestion, the Ure2p 
protein synthesized in WGE was proteolysed much more slowly 
compared to that synthesized in RRL; this displays fragments of 
about 31-34 kDa, persisting over 8 min. Thus, the digestion rate 
and pattern of the protein synthesized in WGE, unlike that 
synthesized in RRL, revealed characteristic features of the 
[URE31 prion-like isoform of the Ure2p protein [Masison, D.C. 
and Wickner, R.B. (1995) Science 270,93-95]. Chloramphenicol 
acetyltransferase, synthesized under the same conditions, dif-
fered fundamentally in its proteolytic sensitivity toward protein-
ase K (PK); in the RRL system it was more slowly digested than 
in WGE, proving specific PK inhibitors to be absent in both 
systems. Posttranslational addition of the WGE to the RRL-
synthesized Ure2p does not protect Ure2p from efficient PK 
degradation either. The differences in Ure2p degradation may be 
ascribed to a specific structure or specific states of association of 
Ure2p synthesized in WGE; obviously, they yield a protein that 
mimics the behavior of the Ure2p in |URE3] yeast strains. The 
present data suggest that particular conditions of the Ure2p 
protein translation and/or certain cellular components (accessory 
proteins and extrinsic factors), as well as the nature of the 
translation process itself, could affect the intracellular folding 
pathway of Ure2p leading to the de novo formation of the prion 
[URE3] isoform. 
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1. Introduction 
Saccharomyces cerevisiae can use alternative nitrogen sour-
ces such as arginine, urea and allantoin, if preferred nitrogen 
sources like glutamine, asparagine, or ammonium ions are not 
available in the medium. The basis of this selectivity is known 
as nitrogen catabolite repression [1]. Utilization of alternative 
nitrogen sources requires both the relief of nitrogen repression 
and the induction of specific permeases and enzymes. The 
products of the GLN3 and URE2 genes are required for the 
appropriate transcription of numerous genes in alternative 
nitrogen assimilatory pathways [2-5]. GLN3 is known to ac-
tivate their transcription when rich nitrogen sources are not 
available, and Ure2p appears to repress their transcription 
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when alternative nitrogen sources are not needed [1-5]. How-
ever, the repression can be overcome in yeast [URE3] strains 
[6]. A cytoplasmically inherited element, [URE3], allows yeast 
to use ureidosuccinate in the presence of ammonium [1,6,7]. 
[URE3] is a non-Mendelian genetic element that mimics re-
cessive mutations in the chromosomal URE2 gene. Recently it 
was suggested that [URE3] is an altered (prion-like) form of 
the chromosomally encoded Ure2p protein [8]. Several genetic 
and biochemical criteria were proposed to confirm this sug-
gestion and [URE3] was shown to satisfy these criteria [7-9]. 
Evidence supporting the hypothesis that [URE3] represents a 
prion-like element in yeast came from the following observa-
tions: (1) [URE3] can be reversibly cured; (2) [URE3] prop-
agation requires the natural URE2 gene; recessive chromoso-
mal mutants exhibit the same phenotypes as those observed in 
the presence of the respective dominant non-Mendelian ele-
ments ; (3) overproduction of Ure2p increases the frequency of 
cells acquiring [URE3]; (4) [URE3] is a dominant and inva-
sive element [7-9]. 
Proteinase K resistance was among the first criteria to dis-
tinguish between the scrapie (altered PrPSc) form of the mam-
malian prion protein (PrP) and its cellular isoform (PrPc) 
[10,11]; for [URE3] the same holds true [9]. Correspondingly, 
the cellular isoform Ure2p has been suggested to undergo a 
profound conformational change during its conversion into 
the cellular isoform [URE3] [7-9], in accordance with mam-
malian prion proteins [12,13]. 
It has been suggested that [URE3] arises spontaneously 
from the normal cellular isoform of the Ure2p protein, prop-
agating through interactions of the N-terminal domain of the 
proteins [7-9]. The frequency of spontaneous occurrence of 
[URE3] is in the order of 1CT5; it can be enhanced up to 
100-fold upon overexpression of the URE2 gene, or subjecting 
the yeast cells to stress (heat or cold shock, ethanol, etc.) [14]. 
On the other hand, [URE3] can be cured by growing the cells 
in non-mutagenic protein denaturants such as millimolar con-
centration of guanidinium chloride [7-9]. These observation 
lend additional support to the suggestion that [URE3] and 
Ure2p differ in their conformational state, i.e. protein-based 
inheritance in yeast can be determined by the conformational 
variants of the proteins involved. This possibility puts an in-
triguing question in the prion-folding problem, namely: how 
can one and the same gene expressed in a given cellular spe-
cies give rise to different conformers in proportions depending 
on the environmental conditions? This question addresses a 
quite fundamental problem, and also bears on an important 
public health issue linked to prions in general, known to cause 
fatal neurological diseases in humans and animals [12,13]. In 
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fact, two questions could be addressed in connection with the 
prion-folding problem: (1) is the initial conversion of the nor-
mal cellular isoform (PrPc) of the prion protein into its scrapie 
isoform (PrPSc) stochastic and spontaneous, or could certain 
cellular factors and mechanisms affect this process? and (2) is 
the interaction of the PrPSc with PrPc the only one factor 
which is sufficient and necessary for the propagation of the 
conversion? 
The yeast prion-like element Ure2p may be considered a 
convenient object to elucidate the mechanism of the partition-
ing between the different conformers [7-9]. Here, we address 
this possibility by translating the Ure2p mRNA in various 
cell-free extracts. The results show that, depending on the 
factors present in the cell-free translation systems, the newly 
synthesized Ure2p protein differs in its structural properties. 
The Ure2p protein synthesized in vitro in wheat germ extract 
system (WGE) possesses major properties of the [URE3] 
prion isoform, displaying much higher resistance to proteinase 
K digestion, in contrast to the protein synthesized in rabbit 
reticulocyte lysate cell-free system (RRL). If these results ap-
ply in vivo, the occurrence and cytoplasmic inheritance of the 
[URE3] condition could result from the disbalance of the 
cellular translation apparatus, favoring the Ure2p prion-like 
isoform over the normal Ure2p conformer. Whether this is a 
co- or posttranslational process including other proteins is an 
open question. 
2. Materials and methods 
2.1. Plasmid construction 
The pFL39URE2 and pBeGB/HFCURE2 plasmids bearing the 
genes for the natural Ure2p and modified protein (containing ¿-ter-
minal hexahistidyl tail) were constructed by Christophe Cullin and 
Elisabeth Guillemet (to be published). The pUC18:IM3/CI-l plasmid 
containing the chloramphenicol acetyltransferase (CATIII) gene was 
the gift of Prof. W.V. Shaw (University of Leicester). The EcoKl-Xhol 
(1421 bp) fragment bearing the URE2 gene of the pFL39URE2 plas-
mid was inserted into pBluescript II SK+ vector and the HinalW-
EcoRl (1158 bp) fragment of the pBeGB/HFCURE2 plasmid into 
pBluescript II KS~ vector, to obtain the genes under control of the 
T7 promoter. The BamHl-Hindlll (1034 bp) fragment of the pU-
C18:IM3/CI-1 plasmid was inserted into pBluescript II KS~ vector, 
under control of the T7 promoter. 
2.2. In vitro transcription 
The transcription reactions were carried out: (i) following the 
Promega Transcription in vitro systems Technical Manual or (ii) ac-
cording to Gurevich et al. [15] in 100 μΐ (total volume) of 80 mM 
HEPES-KOH buffer, pH 7.5, containing 16 mM MgCl2, 2 mM sper-
midine, 20 mM dithiothreitol (DTT), 3 mM ATP, 3 mM GTP, 3 mM 
UTP, 3 mM CTP, 2.5 μΐ (100 units) of RNasin (Promega), 5 μg of 
either EcoRl (pBSK+/URE2), Xhol (pBKS"/URE2his) or Hindlll 
(pBluescript II KS~ CATIII) linearized DNA templates and 320 units 
of T7 RNA polymerase (Promega). The reactions were carried out at 
37°C for 2.5 h and stopped by phenol/chloroform extraction. The 
transcripts were purified by LiCl precipitation and washed with 70% 
ethanol [16]. The purity and integrity of the RNA molecules were 
checked by 5% PAGE under denaturing conditions in the presence 
of 7 M urea. An aqueous solution (0.6 mg/ml) of the transcripts was 
used in translation experiments. 
2.3. Cell-free protein synthesis 
Cell-free translation of the Ure2p and CATIII mRNAs was per-
formed using either the RRL or WGE in vitro translation systems in 
the presence of [35S]methionine (15 mCi/ml, Amersham) as described 
in the above Promega Technical Manual. The final concentration of 
Ure2p mRNAs in both systems was 132 μg/ml and that of CATIII 
mRNA 128 μg/ml. The translation was carried out at 34°C for 1 h in 
the case of RRL and at 25°C for 1.5 h in the case of the WGE system 
to enrich the same final Ure2p protein concentration in equal volumes 
of the translation systems. Chloramphenicol acetyltransferase trans-
lation was performed for 40 min in the case of RRL and 80 min in the 
case of the WGE system. The translation reactions were stopped by 
the addition of an equal volume of 20 mM Tris-HCl buffer, pH 7.6, 
200 mM KCH3COO, 20 mM Mg(CH3COO)2, 2 mM DTT and 0.2 
mM EDTA cold at 0°C (buffer A). 
2.4. Proteinase K susceptibility of the in vitro synthesized Ure2p and 
CATIII 
Proteinase K (0.2-0.5 μg, Stratagene) was added to 25 μΐ fractions 
of the stopped translation mixtures and the incubation was performed 
at 37°C. Periodically 3 μΐ aliquots were removed, mixed with 50 mM 
Tris-HCl, electrophoresis sample buffer pH 6.8, containing 4% SDS, 
2% mercaptoethanol (v/v), 12% glycerol (w/v), 0.01% Serva Blue G 
and immediately incubated at 80°C for 10 min. The samples were 
further analyzed by electrophoresis according to [17] in a 10% T, 
3% C or 16.5% T, 6% C gel, overlaid with a 4% T, 3% C stacking 
gel. 'Rainbow [14C]methylated colored proteins' (MW = 2350^16000 
Da, Amersham) were used as molecular weight markers. Gels were 
fixed, dried in vacuo and subjected to autoradiography using the 
Molecular Dynamics Phosphorlmager. 
2.5. Miscellaneous 
Molecular cloning was performed following general procedures de-
scribed in [16]. 
Radioactivity was monitored using a Packard 2200CA Tri-Carb 
liquid scintillation analyzer. Trichloroacetic acid precipitable radioac-
tivity was determined in sample aliquots spotted onto GF/C (What-
man) glass filters after NaOH hydrolysis. Protein determination was 
done using the bicinchoninic acid assay [18]. 
3. Results and discussion 
Synthesis of Ure2p made use of either the RRL or WGE 
cell-free translation systems. In both cases equal amounts of 
mRNAs were subjected to translation, optimizing the reaction 
so that equal amounts of the proteins ( ~ 0.4 ng) were synthe-
sized in a total final volume of 50 μΐ of both systems. The 
translation reactions were stopped by the addition of an equal 
volume of cold on ice buffer (A) and subjected to digestion 
with proteinase K (PK) as described in Sections 2.3 and 2.4. 
The translation of the Ure2p in either the RRL or the 
WGE cell-free system resulted in a major polypeptide of 
about 42 kDa (Fig. 1), in accordance with its known mobility 
on SDS-PAGE [9] and close to the molecular weight of the 
Ure2p protein calculated from its amino acid sequence (40 
kDa). An additional 30 kDa fraction may be ascribed to an 
'abortive' polypeptide (apparently the product of premature 
termination and release of the incomplete nascent Ure2p 
chains). Interestingly, a polypeptide of the same size was 
also detected in vivo during the expression of Ure2p in yeast 
cells by immunoblotting with a polyclonal antibody to Ure2p 
[9]. The major polypeptide synthesized in RRL was digested 
by PK in less than 1 min, yielding major fragments of 18-19 
kDa as well as minor polypeptides of 6-7 and 4 kDa respec-
tively (Fig. 1, lane Γ RRL). The major species are digested 
slowly (life-time 5 min); the 6-7 kDa fragment is very short-
lived, whereas the 4 kDa fragment resists proteolysis for at 
least 25 min. For the polypeptide synthesized in WGE, the 
proteolysis pattern closely resembled that obtained in RRL; 
however, the kinetics of proteolysis differed significantly (Fig. 
1, lane Γ-25' WGE). Most of the 42 kDa polypeptide syn-
thesized in WGE was digested within 1 min into at least three 
fragments, two of 34 and 32 kDa, and one overlapping with 
the 30-31 kDa 'abortive' polypeptide. As in the case of the 
RRL system, a characteristic fragment of about 18-19 kDa 
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Fig. 1. Autoradiogram of SDS gel electrophoresis of the Ure2p mRNA cell-free translation products and PK digestion. Numbers at the top of 
the slots indicate the times of digestion by PK (time 0': no protease added). WGE and RRL refer to the cell-free systems used to translate 
Ure2p mRNA. Arrows indicate the positions of molecular weight standards. Molecular mass is given in kDa. Mr refer to the slots with molec-
ular weight standards. A: 0.25 μg of PK was added to a 25 μΐ aliquot of the translation mixture as indicated in Section 2. B: 0.5 μg of PK 
was added to a 25 μΐ aliquot of the translation mixture as indicated in Section 2. 
also appeared, but significantly later in time of digestion. Re-
markably, the digestion pattern of the proteins produced in 
WGE after 15 min of digestion closely resembled that after 
only 1 min of digestion of the proteins produced in RRL. In 
addition, it is important to note that the total endogenous 
protein concentration in RRL exceeded that in WGE three-
fold (98 mg/ml in RRL, 31 mg/ml in WGE), meaning that the 
relative ratio of PK to the total endogenous as well as to the 
newly synthesized protein content is 3 times higher in WGE. 
If the rate of proteolysis is assumed to be first-order with 
respect to the protease concentration, this would mean that 
the proteolysis kinetics is about 40 times faster for Ure2p 
synthesized in RRL compared to the protein produced in 
WGE. Similar digestion features were also observed for the 
Ure2p protein containing a His-tag at its C-terminal end (Fig. 
2). Ure2p His-tagged protein has also been shown to give rise 
to the [URE3] yeast phenotype (C. Cullin, unpublished data). 
It needs to be emphasized that differences in PK digestion are 
relative. Increasing the concentration of PK two-fold (0.5 μg 
PK per 0.1 ng of the newly synthesized Ure2p) resulted in a 
more efficient degradation of the protein translated in WGE 
(Fig. IB). However, even under this condition the difference in 
PK digestion was significant: the 31-34 kDa fragments per-
sisted for more than 3 min in the case of the protein synthe-
sized in WGE; the major 18-19 kDa fragment remained un-
affected for over 25 min. In this time range, the degradation 
of the protein synthesized in RRL is practically complete (Fig. 
IB). It should be underlined that Ure2p synthesized in both 
cell-free systems was stable until PK was added and no differ-
ence in peptide patterns was observed upon incubation of the 
translation mixtures at 37°C for 25 min (not shown). It should 
also be underlined that the indicated differences of Ure2p 
degradation are not due to specific PK inhibitors present in 
the WGE system; rather they are attributable to structural 
differences or to variations in the state of association of 
Ure2p. Control experiments to support this made use of the 
in vitro synthesis of chloramphenicol acetyltransferase in both 
cell-free systems. PK digestion here resulted in a lower effi-
ciency for the RRL system compared to WGE (Fig. 3). This 
finding may be attributed to the fact that the overall concen-
tration of endogenous proteins in RRL is 3 times higher that 
in WGE. Posttranslational addition of WGE (up to 80% of its 
Fig. 2. Autoradiogram of SDS gel electrophoresis of the Ure2p His-
tailed mRNA cell-free translation products and PK digestion. Num-
bers at the top of the slots indicate the times of digestion by PK 
(time 0': no protease added). 0.2 μg of PK was added to a 25 μΐ 
aliquot of the translation mixture as indicated in Section 2. WGE 
and RRL refer to the cell-free systems used to translate Ure2p 
mRNA. Arrows indicate the positions of molecular weight stand-
ards. Molecular mass is given in kDa. Mr refer to the slots with 
molecular weight standards. 
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Fig. 3. Autoradiogram of SDS gel electrophoresis of the CATIII 
mRNA cell-free translation products and PK digestion. Numbers at 
the top of the slots indicate the times of digestion by PK (time 0': 
no protease added). 0.25 μg of PK was added to a 25 μΐ aliquot of 
the translation mixture as indicated in Section 2. WGE and RRL 
refer to the cell-free systems used to translate CATIII mRNA. Ar-
rows indicate the positions of molecular weight standards. Molecu-
lar mass is given in kDa. Mr refer to the slots with molecular 
weight standards. 
fragment observed in our experiments originates from the N-
terminal part of the Ure2p protein. This fragment displays 
similar mobility on SDS-PAGE as revealed after PK treat-
ment of the C-terminal His-tagged and wild type Ure2p pro-
tein run on one and the same gel (not shown). 
The results presented clearly indicate that [URE3] can arise 
nonstochastically and that the cellular environment could af-
fect the Ure2p intracellular folding pathway. 
As has been previously reported [19-21], the specific proper-
ties of cell-free translation systems can affect protein folding 
in vivo. In the case of the precursor of liver mitochondrial 
aspartate aminotransferase (pmAspAT), the RRL system 
seems to contain some relevant factors that are effective in 
protein folding, but absent in the WGE system [20,21]. Fully 
folded pmAspAT is known to be largely resistant to trypsin 
hydrolysis. The enzyme synthesized in vitro in WGE, unlike 
that in RRL, does not become trypsin resistant. Obviously, it 
is partially misfolded in contrast to the enzyme obtained by 
the in vitro synthesis in RRL [20,21]. The differences in Hsp70 
association between the two forms of pmAspAT support the 
assumption that early in translation one and the same poly-
peptide chain may exhibit different structural features in the 
two cell-free systems. The stability of the Hsp70 complex with 
the WGE enzyme confirms its non-native conformation 
[20,21]. The same kind of partitioning between the native 
and a misfolded state may be assumed for Ure2p. However, 
in both cases it is unclear what the misfolded proteins are. In 
the given context an alternative explanation could be that the 
WGE system contains all the necessary factors, but that they 
final concentration in the standard WGE translation mixture, 
Fig. 4) does not protect Ure2p, synthesized in RRL from 
efficient digestion by PK, proving once again that specific 
PK inhibitors are absent in WGE. Neither the full-length 
nor the characteristic 31-34 kDa fragments could be observed 
in this case in contrast to the digestion of the protein synthe-
sized in WGE (compare Figs. 1A and 4). Thus, one can con-
clude that the observed difference in Ure2p degradation could 
be attributed to the different folding states of the protein 
synthesized in WGE and RRL. The slight difference in 
Ure2p degradation in the RRL+WGE condition in compar-
ison to the pure RRL mixture could be evidently ascribed to 
the higher overall protein concentration in the RRL+WGE 
mixture. 
It should be emphasized that similar differences regarding 
the time scale and the presence of 30-32 kDa fragments were 
previously demonstrated in PK-dependent degradation of 
Ure2p expressed in either [URE3] or wild type yeast cells 
[9]. Thus, we conclude that the isoform of the Ure2p protein 
with the characteristic PK resistance of the [URE3] prion-like 
element can be produced in the WGE system unlike in the 
RRL. It should also be stressed that features of degradation 
of the major 18-19 kDa Ure2p proteolytic fragment closely 
resemble those of the N-terminal Ure2p prion inducing do-
main fragment [9]. This fragment separately expressed in wild 
type and prion containing yeast cells displays differential re-
sistance to PK digestion [9]. We argue that the 18-19 kDa 
Fig. 4. Autoradiogram of SDS gel electrophoresis of the Ure2p 
mRNA cell-free translation products and PK digestion. Numbers at 
the top of the slots indicate the times of digestion by PK (time 0': 
no protease added). RRL+WGE and RRL refer to the conditions 
used to analyse Ure2p PK digestion. After 1 h of incubation, the 
RRL translation reaction was stopped by the addition of cold in ice 
buffer A (see Section 2) and the reaction mixtures were subdivided 
into two equal portions. The WGE extract (80% of its final concen-
tration in the standard WGE translation mixture) was added to one 
of the portions (RRL+WGE) and an equal volume of the half-con-
centrated buffer A to the other (RRL). The ratio of PK to the 
Ure2p synthesized in RRL was 0.25 μg PK per 0.1 ng of the 
Ure2p, as described in Fig. la. Arrows indicate the positions of mo-
lecular weight standards. Molecular mass is given in kDa. Mr refer 
to the slots with molecular weight standards. 
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are not adapted to assist the production of the native Ure2p 
state. Hamster PrP expressed in vitro in either the WGE or 
the RRL cell-free system supplemented with microsomal 
membranes was also shown to represent different folding 
states [22]. The characteristic transmembrane form of the 
PrP was observed in the WGE system in contrast to the native 
completely translocated (secretory) form observed in RRL. 
Likewise it was concluded that hamster PrP synthesized in 
vitro could display two system-dependent topologies. 
A fundamental question in the pathogenesis of the prion 
diseases is the mechanism of conversion of the cellular iso-
form of prion protein (PrPc) into the infectious scrapie iso-
form (PrPSc). It was suggested that conversion of PrPc into 
PrPSc occurs by a conformational mechanism due to a post-
translational interaction of PrPSc with PrPc [12,13]. 
Similar mechanisms were postulated to explain the origin of 
the yeast prion-like proteins [URE3] and [PSI] [7,14,23]. 
However, several lines of evidence call the postulated mech-
anisms into question for at least two reasons: (i) conversion of 
mammalian PrP0 into PrPSc (observed in vitro) requires sig-
nificant pretreatment of PrPc (PrPSc) with 1-6 M GdnHCl 
[23,24], conditions one can hardly achieve in vivo; (ii) at least 
in the case of the yeast [PSI] prion-like element it was shown 
that several chaperones and in particular Hspl04 and Ssal 
provoke efficient elimination of [PSI], being overexpressed, 
whereas an intermediate amount of Hspl04 is required for 
the propagation of [PSI] [14]. 
In an attempt to elucidate the mechanism by which [URE3] 
can arise de novo, we have studied the resistance to proteinase 
K digestion of the Ure2p yeast prion-like protein after its 
synthesis in vitro using either a mammalian system, rabbit 
reticulocyte lysate, or a plant system, wheat germ extract. 
The results of the present study indicate that Ure2p protein 
when newly synthesized in WGE (unlike the RRL protein) 
reveals characteristics of the [URE3] prion-like isoform. This 
means that particular conditions of Ure2p translation can lead 
to either the Ure2p or the [URE3] variant. This observation 
strongly suggests that in vivo S. cerevisiae can produce 
[URE3] de novo. Evidence showing that overproduction 
of Ure2p increases the frequency of cells acquiring [URE3] 
[7-9] suggests that the [URE3] isoform could result from the 
disbalance of the protein biosynthetic apparatus. Similar 
mechanisms could explain the initial formation of the PrPSc 
isoform in the case of mammalian prion diseases. Different 
cytosolic factors are assumed to contribute to determine the 
final proper protein conformation in vivo, ranging from those 
controlling ribosome traffic to chaperones, stress proteins and 
foldases. The particular balance of these components is ex-
pected to be specific for a given organism. Very recently the 
structure of the full-length recombinant murine prion protein, 
mPrP (23-231) has been characterized by UV-CD and NMR 
[25,26]. Their data showed that N-terminal (23-120) part of 
the protein is represented (in aqueous solution) by a flexible 
extended coil, which could enable structural transitions of 
PrP c to PrPSc in vivo [25,26] and apparently be an 'attractive' 
target for chaperones. Similarly one can expect the same and 
for the N-terminal part of the prion-like elements of yeasts. 
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